Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Second approvable letter issued for duloxetine

Sep. 4, 2003

Bayer researchers describe two novel series of Rho kinase inhibitors

Sep. 3, 2003

Levitra receives FDA approval

Aug. 25, 2003

Preliminary results of North American Cystistat trial for interstitial cystitis

Aug. 22, 2003

Improved safety profile for transdermal oxybutynin vs. oral tolterodine in overactive bladder

Aug. 19, 2003

Yamanouchi and GlaxoSmithKline to copromote Vesicare in U.S.

Aug. 13, 2003

Two novel series of VR1 antagonists for urinary incontinence, pain, etc.

Aug. 12, 2003

Levitra is effective in men of diverse ethnic origin

Aug. 11, 2003

Collaborative Study Group to conduct KRX-101 phase II/III program

Aug. 7, 2003

Sustained symptom relief induced by tamsulosin in BPH

Aug. 1, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.